These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15691290)

  • 1. Pisa syndrome in a cohort of Alzheimer's disease patients.
    Vanacore N; Suzzareddu G; Maggini M; Casula A; Capelli P; Raschetti R
    Acta Neurol Scand; 2005 Mar; 111(3):199-201. PubMed ID: 15691290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease.
    Huvent-Grelle D; Roche J; Camus FE; Dewailly P; Puisieux F
    J Am Geriatr Soc; 2007 Sep; 55(9):1472-5. PubMed ID: 17767692
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Pisa syndrome and cholinesterase inhibitor use for elderly adults with Alzheimer's disease.
    Huvent-Grelle D; Boulanger E; Puisieux F
    J Am Geriatr Soc; 2014 Dec; 62(12):2450-3. PubMed ID: 25516048
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation between cholinesterase inhibitor and Pisa syndrome.
    Kwak YT; Han IW; Baik J; Koo MS
    Lancet; 2000 Jun; 355(9222):2222. PubMed ID: 10881902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients].
    Huvent-Grelle D; Roche J; Gaxatte C; Dewailly P; Puisieux F
    Presse Med; 2009 Jan; 38(1):150-3. PubMed ID: 18986791
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors.
    Kapaki E; Ilias I; Paraskevas GP; Theotoka I; Christakopoulou I
    Acta Neurobiol Exp (Wars); 2003; 63(4):389-92. PubMed ID: 15053263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
    Senanarong V; Poungvarin N; Phanthumchinda K; Thavichachart N; Chankrachang S; Praditsuwan R; Nidhinandana S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S12-8. PubMed ID: 19562980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
    Bogardus ST
    J Psychiatry Neurosci; 2001 Nov; 26(5):425. PubMed ID: 11762210
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study.
    Zannas AS; Okuno Y; Doraiswamy PM
    Pharmacotherapy; 2014 Mar; 34(3):272-8. PubMed ID: 24127392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
    Prasher VP; Fung N; Adams C
    Int J Geriatr Psychiatry; 2005 May; 20(5):496-7. PubMed ID: 15852458
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Pisa syndrome after administration of a single dose of donepezil.
    Ioannidis P; Maiovis P; Balamoutsos G; Karacostas D
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E26. PubMed ID: 23037668
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project.
    Franchi C; Lucca U; Tettamanti M; Riva E; Fortino I; Bortolotti A; Merlino L; Pasina L; Nobili A
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):497-505. PubMed ID: 21432941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.
    Geldmacher DS
    Expert Rev Neurother; 2004 Jan; 4(1):5-16. PubMed ID: 15853610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohort.
    Gillette-Guyonnet S; Cortes F; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):69-73. PubMed ID: 15791348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer dementia].
    Hock C; Nitsch RM
    Praxis (Bern 1994); 2000 Mar; 89(13):529-40. PubMed ID: 10776055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
    Stübner S; Padberg F; Grohmann R; Hampel H; Hollweg M; Hippius H; Möller HJ; Rüther E
    J Clin Psychiatry; 2000 Aug; 61(8):569-74. PubMed ID: 10982199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.